Literature DB >> 1429872

Glucocorticoid and retinoid regulation of alpha-2 type I procollagen promoter activity.

J R Perez1, S Shull, G J Gendimenico, R J Capetola, J A Mezick, K R Cutroneo.   

Abstract

Glucocorticoids decrease type I procollagen synthesis by decreasing the steady state levels of procollagen mRNAs and mRNA synthesis. The present studies were undertaken to determine the functional sequences of the pro alpha 2(I) collagen gene required for the glucocorticoid-mediated decrease of type I procollagen mRNA synthesis. Embryonic mouse fibroblasts were stably transfected with the pR40 DNA CAT construct containing the 5' flanking region fragment from -2048 to +54 and the intronic fragment from +418 to +1524 of the mouse alpha 2(I) collagen gene. Dexamethasone treatment of these pR40 transfected fibroblasts resulted in a significant decrease in CAT activity which agrees with the glucocorticoid-mediated decrease of the steady state levels of type I procollagen mRNAs. To determine the possible role of the first intron fragment in the dexamethasone-mediated decrease of CAT activity, pR36, a CAT plasmid containing the first intron fragment and the SV40 early promoter, was transfected into mouse fibroblasts and treated with dexamethasone. No significant decrease in CAT activity was observed. The dexamethasone-mediated response was then localized within the 5' flanking region by preparing a series of constructs containing internal deletions and transfecting these plasmids into mouse fibroblasts. The regions -2048 to -981 and -506 to -351 were required for the dexamethasone response of gene activity. However, the DNA stretch from -981 to -506 was not. Analysis of the DNA sequences of these regions revealed a single GRE at -1023 to -1018 and a modified doublet at -873 to -856.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429872     DOI: 10.1002/jcb.240500107

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

1.  Transcriptional control in keratinocytes and fibroblasts using synthetic ligands.

Authors:  R A Freiberg; S N Ho; P A Khavari
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

2.  The effects of methylprednisolone and halofuginone on preventing esophageal and hypopharyngeal fibrosis in delivered radiotherapy.

Authors:  Hakan Dabak; Turgut Karlidag; Nusret Akpolat; Erol Keles; Hayrettin Cengiz Alpay; Meltem Serin; Irfan Kaygusuz; Sinasi Yalcin; Ozgur Isik
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-04-03       Impact factor: 2.503

3.  Influence of inhaled beclomethasone and montelukast on airway remodeling in mice.

Authors:  Rania R Abdel Aziz; Nadia Y Helaly; Khaled R Zalata; Nariman M Gameil
Journal:  Inflammopharmacology       Date:  2012-02-22       Impact factor: 4.473

4.  Type 1 procollagen as a marker of severity of scarring after sternotomy: effects of topical corticosteroids.

Authors:  Y Riaz; H T Cook; A Wangoo; B Glenville; R J Shaw
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

5.  Topical steroids for chronic wounds displaying abnormal inflammation.

Authors:  D C Bosanquet; A Rangaraj; A J Richards; A Riddell; V M Saravolac; K G Harding
Journal:  Ann R Coll Surg Engl       Date:  2013-05       Impact factor: 1.891

6.  Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.

Authors:  Ioannis Skiadas; Angelos Pefanis; Apostolos Papalois; Aspasia Kyroudi; Helen Triantafyllidi; Thomas Tsaganos; Helen Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2007-06-11       Impact factor: 5.191

Review 7.  Topical steroids in burn patients: A systematic review of the literature and a descriptive analysis of topical KENACOMB use at a major tertiary burn centre.

Authors:  Michelle F Duff; Carl Lisec
Journal:  JPRAS Open       Date:  2022-05-13

8.  Deletion of mesenchymal glucocorticoid receptor attenuates embryonic lung development and abdominal wall closure.

Authors:  Aiqing Li; Rowan Hardy; Shihani Stoner; Jan Tuckermann; Markus Seibel; Hong Zhou
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

9.  Anti-inflammatory ethosomal nanoformulation in combination with iontophoresis in chronic wound healing: An ex vivo study.

Authors:  Reza Mombeiny; Shima Tavakol; Mostafa Kazemi; Mehdi Mehdizadeh; Akbar Hasanzadeh; Mohammad Karimi Babaahmadi; Ali Abedi; Peyman Keyhanvar
Journal:  IET Nanobiotechnol       Date:  2021-10-18       Impact factor: 1.847

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.